EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Artificial intelligence and multiomics integration for Parkinson’s disease drug development

Seulah Lee, Jaehoon Kim, Hae-Un Jung, Dayea Kim, Eunji Cho, Ye-Jin Kim, Young Rae Ji, Younghoon Go, Parkyong Song, Yong-Seok Oh, Jong Hyuk Yoon

Molecules and Cells · 2026-05 · 49 (5) · 100343

DOI: 10.1016/j.mocell.2026.100343 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules and Cells, 2026-05. Verfasst von Seulah Lee und 10 weiteren Autor:innen. Beteiligte Einrichtung: Neurodegenerative Diseases Research Group, Korea Brain Research Institute, Daegu, Republic of Korea. Hauptthemen laut MEDLINE: Parkinson Disease, Multiomics, Artificial Intelligence, Drug Development. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Korea Ministry of Science and ICT, National Research Foundation of Korea, Korea Brain Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseMultiomicsArtificial IntelligenceDrug DevelopmentDrug DiscoveryHumansAnimalsGenomicsProteomics

Stichwörter der Autor:innen

Artificial intelligenceDrug discoveryMultiomicsParkinson’s disease

Autor:innen und Institutionen

  • Neurodegenerative Diseases Research Group, Korea Brain Research Institute, Daegu, Republic of Korea.
  • New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation (K-MEDI Hub), Daegu, Republic of Korea.
  • Sensory & Motor System Research Group, Korea Brain Research Institute, Daegu, Republic of Korea.
  • Korean Medicine (KM)-Application Center, Korea Institute of Oriental Medicine, Daegu, Republic of Korea.
  • Department of Convergence Medicine, School of Medicine, Pusan National University, Yangsan, Republic of Korea.
  • Department of Brain Sciences, Daegu-Gyeongbuk Institute of Science and Technology (DGIST), Daegu, Republic of Korea.

Förderung

  • Korea Ministry of Science and ICT
  • National Research Foundation of Korea
  • Korea Brain Research Institute

Zitieren

APA

Lee, S., Kim, J., Jung, H. U., Kim, D., Cho, E., Kim, Y. J., Ji, Y. R., Go, Y., Song, P., Oh, Y. S., & Yoon, J. H. (2026). Artificial intelligence and multiomics integration for Parkinson’s disease drug development. Molecules and Cells, 49(5), 100343. https://doi.org/10.1016/j.mocell.2026.100343

Vancouver

Lee S, Kim J, Jung HU, Kim D, Cho E, Kim YJ, et al. Artificial intelligence and multiomics integration for Parkinson’s disease drug development. Molecules and Cells. 2026;49(5):100343. doi:10.1016/j.mocell.2026.100343

BibTeX
@article{Lee2026,
  author = {Lee, Seulah and Kim, Jaehoon and Jung, Hae-Un and Kim, Dayea and Cho, Eunji and Kim, Ye-Jin and Ji, Young Rae and Go, Younghoon and Song, Parkyong and Oh, Yong-Seok and Yoon, Jong Hyuk},
  title = {Artificial intelligence and multiomics integration for Parkinson’s disease drug development},
  journal = {Molecules and Cells},
  year = {2026},
  volume = {49},
  number = {5},
  pages = {100343},
  doi = {10.1016/j.mocell.2026.100343}
}
Kostenlos starten →